Efficacy and Safety of DWP450 Compared With Botox in Moderate to Severe Glabellar Line

Clinical trial NCT01629875 · COMPLETED

Trial details

NCT number: NCT01629875
Sponsor: Daewoong Pharmaceutical Co. LTD.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Moderate to Severe Glabellar Line

Start date: 2012-03-01
Primary completion: 2012-08-01
Enrollment: 268

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.